![]() | |
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C21H29NO |
Molar mass | 311.469 g·mol−1 |
3D model (JSmol) | |
| |
|
U-41792 is a small molecule developed by the Upjohn Company as a hypobetalipoproteinemic agent, meaning it lowers levels of beta-lipoproteins, including low-density lipoprotein (LDL) such as apolipoprotein B, in the blood. [1] Elevated LDL levels can lead to early-onset atherosclerosis and increase the risk of heart problems. [2]
U-41792 demonstrated its ability to reduce lipid levels in hyperlipemic rats. [3] [4] [5]
In order to synthesize U-41792, the alcohol of adamantane called 1-adamantanol is reacted with sodium to generate its corresponding alkoxide. This alkoxide then undergoes a nucleophilic aromatic substitution on p-fluoronitrobenzene to form the corresponding ether. This ether is then reduced and alkylated to give U-41792. [1]
N.B. 4-Fluoronitrobenzene has dual use in the synthesis of B777-81 & WAY-213,613 also.